166 related articles for article (PubMed ID: 34773645)
1. Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration.
Cosgarea I; McConnell AT; Ewen T; Tang D; Hill DS; Anagnostou M; Elias M; Ellis RA; Murray A; Spender LC; Giglio P; Gagliardi M; Greenwood A; Piacentini M; Inman GJ; Fimia GM; Corazzari M; Armstrong JL; Lovat PE
Br J Dermatol; 2022 Apr; 186(4):694-704. PubMed ID: 34773645
[TBL] [Abstract][Full Text] [Related]
2. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas.
Ellis R; Tang D; Nasr B; Greenwood A; McConnell A; Anagnostou ME; Elias M; Verykiou S; Bajwa D; Ewen T; Reynolds NJ; Barrett P; Carling E; Watson G; Armstrong J; Allen AJ; Horswell S; Labus M; Lovat PE
Br J Dermatol; 2020 Jan; 182(1):156-165. PubMed ID: 31056744
[TBL] [Abstract][Full Text] [Related]
3. Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Ewen T; Husain A; Stefanos N; Barrett P; Jones C; Ness T; Long A; Horswell S; Bosomworth H; Lowenstein J; Richardson G; Swan D; McConnell A; Rose A; Andrew T; Reynolds N; Malvehy J; Carrera C; Alos L; Mailer S; Helm T; Ding L; Bogner P; Podlipnik S; Puig S; McArthur GA; Paragh G; Labus M; Sloan P; Armstrong JL; Lovat PE
Br J Dermatol; 2024 Mar; 190(4):549-558. PubMed ID: 38006317
[TBL] [Abstract][Full Text] [Related]
4. Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis.
McCarty MF; Bielenberg DR; Nilsson MB; Gershenwald JE; Barnhill RL; Ahearne P; Bucana CD; Fidler IJ
Melanoma Res; 2003 Aug; 13(4):379-87. PubMed ID: 12883364
[TBL] [Abstract][Full Text] [Related]
5. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
Schmid P; Itin P; Rufli T
Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
[TBL] [Abstract][Full Text] [Related]
6. The combined immunohistochemical expression of AMBRA1 and SQSTM1 identifies patients with poorly differentiated cutaneous squamous cell carcinoma at risk of metastasis: A proof of concept study.
Alexander MH; Cousins WJ; Ewen T; South AP; Lovat P; Stefanos N
J Cutan Pathol; 2024 Jun; 51(6):450-458. PubMed ID: 38421158
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma.
Tang DY; Ellis RA; Lovat PE
Front Oncol; 2016; 6():236. PubMed ID: 27882308
[TBL] [Abstract][Full Text] [Related]
8. AMBRA1 has an impact on melanoma development beyond autophagy.
Di Leo L; De Zio D
Autophagy; 2021 Jul; 17(7):1802-1803. PubMed ID: 34156327
[TBL] [Abstract][Full Text] [Related]
9. Epidermal β-catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages.
Lichtenberger BM; Mastrogiannaki M; Watt FM
Nat Commun; 2016 Feb; 7():10537. PubMed ID: 26837596
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis.
Gold LI; Jussila T; Fusenig NE; Stenbäck F
J Pathol; 2000 Apr; 190(5):579-88. PubMed ID: 10727984
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes.
Davies M; Prime SS; Eveson JW; Price N; Ganapathy A; D'Mello A; Paterson IC
Int J Exp Pathol; 2012 Apr; 93(2):148-56. PubMed ID: 22414291
[TBL] [Abstract][Full Text] [Related]
12. TGF-β-Mediated Modulation of Cell-Cell Interactions in Postconfluent Maturing Corneal Endothelial Cells.
Santerre K; Cortez Ghio S; Proulx S
Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):3. PubMed ID: 36194422
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-associated expression of transforming growth factor-beta isoforms.
Van Belle P; Rodeck U; Nuamah I; Halpern AC; Elder DE
Am J Pathol; 1996 Jun; 148(6):1887-94. PubMed ID: 8669474
[TBL] [Abstract][Full Text] [Related]
14. Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.
Frias A; Di Leo L; Antoranz A; Nazerai L; Carretta M; Bodemeyer V; Pagliuca C; Dahl C; Claps G; Mandelli GE; Andhari MD; Pacheco MP; Sauter T; Robert C; Guldberg P; Madsen DH; Cecconi F; Bosisio FM; De Zio D
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868570
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
[TBL] [Abstract][Full Text] [Related]
16. The Research Progress in Transforming Growth Factor-β2.
Wang MY; Liu WJ; Wu LY; Wang G; Zhang CL; Liu J
Cells; 2023 Nov; 12(23):. PubMed ID: 38067167
[TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance.
Fujimoto T; Inoue-Mochita M; Iraha S; Tanihara H; Inoue T
J Biol Chem; 2021 Sep; 297(3):101070. PubMed ID: 34389355
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC
J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
[TBL] [Abstract][Full Text] [Related]
19. The autophagy protein Ambra1 regulates gene expression by supporting novel transcriptional complexes.
Schoenherr C; Byron A; Griffith B; Loftus A; Wills JC; Munro AF; von Kriegsheim A; Frame MC
J Biol Chem; 2020 Aug; 295(34):12045-12057. PubMed ID: 32616651
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.
Do TV; Kubba LA; Du H; Sturgis CD; Woodruff TK
Mol Cancer Res; 2008 May; 6(5):695-705. PubMed ID: 18505915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
